Pharmaceutical products occupy a unique position in the landscape of product liability law. Medicines are inherently capable of causing harm even when properly manufactured and correctly administered, yet society depends on their availability for the preservation of health and the treatment of disease. This tension between therapeutic benefit and inherent risk has generated a complex body of legal doctrine governing the liability of pharmaceutical manufacturers for adverse drug reactions suffered by patients.
Mr. Amanjot Singh Mann* (Mon,) studied this question.